Jaguar Health Inc. (JAGX)

AI Score

Unlock

11.06

3.00 (37.22%)

At close: Apr 25, 2025, 3:59 PM

10.89

-1.51%

After-hours: Apr 25, 2025, 05:58 PM EDT

Dividends

No dividend history available for Jaguar Health Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Full Definition

Related Stocks

Company	Dividend Yield

Dividend Rankings

JAGX News

1 week ago · Proof-of-Concept Data for Rare Disease Indications MVID and SBS-IF for Jaguar Health's Crofelemer to be Presented at April 2025 ELITE PED-GI Congress - accessnewswire.com
1 week ago · Jaguar Health Announces Significant Results in Breast Cancer Patients Accepted for Presentation at Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting - accessnewswire.com
2 weeks ago · Napo Pharmaceuticals, a Jaguar Health Family Company, Exhibiting at the Oncology Nursing Society (ONS) Congress for the FDA-Approved Gelclair Oral Mucositis Prescription Product - accessnewswire.com
3 weeks ago · Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - accessnewswire.com
3 weeks ago · Jaguar Health Announces Closing of Bridge Financing Priced At-The-Market Under Nasdaq Rules - accessnewswire.com
3 weeks ago · Jaguar Health, Inc. (JAGX) Q4 2024 Earnings Call Transcript - seekingalpha.com
3 weeks ago · Jaguar Health Reports 2024 Financials: 2024 Net Revenue Up Approximately 20% Over 2023 - accessnewswire.com
4 weeks ago · 83.33% of Veterinary Oncologists Highlight Importance of Jaguar Health's FDA Conditionally Approved Canalevia-CA1 as a Non-Antibiotic Treatment for Chemotherapy-Induced Diarrhea (CID) in Dog's in New Survey - accessnewswire.com
4 weeks ago · Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget Study - accessnewswire.com
1 month ago · Jaguar Health Presenting March 27 at Emerging Growth Conference and Holding Investor Webcast March 31 Regarding Q4 2024 Financials & Near-Term Catalysts - accessnewswire.com